Abstract
Rare diseases are frequent in pediatrics. In university children‘s hospitals almost 60% of children treated as inpatients suffer from rare diseases. As rare diseases in pediatrics are often severe, complex and chronic, affected families have a high disease burden. The burden is particularly severe in cases with an unclear or unknown diagnosis because the uncertainty of the child’s prognosis adds to the burden of the current suffering and in some cases the molecular diagnosis will enable a new targeted treatment option. The innovation fund project TRANSLATE-NAMSE, financed by the Federal Joint Committee (GBA), has previously evaluated the possibility of improved diagnostics for children and adolescents with undiagnosed rare diseases. Based on interdisciplinary case conferences and supported by the implementation of exome sequencing, 30% of previously uncertain diagnoses could be definitively clarified.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
